Zobrazeno 1 - 10
of 253
pro vyhledávání: '"J.T. Wharton"'
Autor:
David M. Gershenson, Ana Aleman, Michael W. Bevers, J.T. Wharton, Naoto T. Ueno, J. G. Gajewski, C. Levenback, Diane Bodurka-Bevers, Richard E. Champlin, Thomas W. Burke, J. Boyer, Cindy Ippoliti, M. Donato, Paolo Anderlini, Jo Lauppe, Jeffrey J. Molldrem, Judith K. Wolf, Ralph S. Freedman, Martin Korbling, Sergio Giralt, Robert C. Bast
Publikováno v:
Bone Marrow Transplantation. 25:1137-1140
High-dose chemotherapy combined with autologous peripheral blood stem cell transplantation has shown promise as treatment for recurrent or persistent epithelial ovarian cancer. We evaluated the stem cell mobilization regimen of high-dose ifosfamide p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a24c4f52b317cffc886a888223974a79
https://doi.org/10.1038/sj.bmt.1702421
https://doi.org/10.1038/sj.bmt.1702421
Autor:
C. G. Ioannides, B Fisk, Hudson Jm, James L. Murray, J.T. Wharton, Catherine A. O'Brian, Cherylyn A. Savary
Publikováno v:
Journal of Immunotherapy. 18:197-209
The HER-2/neu protooncogene (HER-2) is overexpressed in a significant number of breast and ovarian tumors. Peptides of HER-2 sequence were recently found to reconstitute recognition of cytotoxic T lymphocytes (CTLs) from tumor-associated (TALs) and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f236e5076ad1177574b48cc91303580c
https://doi.org/10.1097/00002371-199511000-00001
https://doi.org/10.1097/00002371-199511000-00001
Autor:
Patricia J. Eifel, E. Neely Atkinson, L. Gastorf, M.Follen Mitchell, J.T. Wharton, Dionne Miller, T.J. Patton, C. Yancey
Publikováno v:
International Journal of Gynecological Cancer. 3:175-182
Small bowel dysfunction is an important problem in patients undergoing radiotherapy for cervical cancer and may take many forms. The spectrum of small bowel dysfunction includes subtle findings such as malabsorption and more obvious complications suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1782e60ef443221ac3bc283e592dc7bb
https://doi.org/10.1046/j.1525-1438.1993.03030175.x
https://doi.org/10.1046/j.1525-1438.1993.03030175.x
Autor:
Lora Thompson, Lamk Lamki, Thomas W. Burke, Joan E. Cunningham, John J. Kavanagh, Elvio G. Silva, James L. Murray, Michael G. Rosenblum, L. Joy Shanken, Lawrence Cheung, J.T. Wharton
Publikováno v:
JNCI Journal of the National Cancer Institute. 83:1629-1636
B72.3 is a murine monoclonal antibody that recognizes a high-molecular-weight tumor-associated glycoprotein (TAG-72). Nine patients with TAG-72-positive ovarian carcinoma or papillary serous carcinoma of the peritoneum received an intraperitoneal inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab10cd8cc404d94e01e95df226d5f47e
https://doi.org/10.1093/jnci/83.22.1629
https://doi.org/10.1093/jnci/83.22.1629
Autor:
Elvio G. Silva, Mitchell Morris, J.T. Wharton, Thomas W. Burke, LM Smiley, David M. Gershenson
Publikováno v:
Obstetrics & Gynecology. 77:271-275
About one-half of cervical cancer patients whose tumors recur after radical surgery have negative lymph nodes and clear resection margins. We evaluated 95 patients with squamous cell tumors who underwent radical hysterectomy and pelvic lymphadenectom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdc85f7fdd6fcc88c883f6620f8387b2
https://doi.org/10.1097/00006250-199102000-00022
https://doi.org/10.1097/00006250-199102000-00022
Autor:
David M. Gershenson, Thomas W. Burke, Creighton L. Edwards, C.A. Stringer, Alan N. Gordon, J.T. Wharton
Publikováno v:
Gynecologic Oncology. 38:305-308
Between October 1985 and January 1989, 33 patients with stage I (31) or clinically occult stage II (2) endometrial cancer at a high risk for recurrence were entered in a prospective study evaluating adjuvant cisplatin, doxorubicin, and cyclophosphami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e7ea5831e768db4dc672655a1e6ce55
https://doi.org/10.1016/0090-8258(90)90063-q
https://doi.org/10.1016/0090-8258(90)90063-q
Autor:
Diane C. Bodurka, James Gajewski, Michael W. Bevers, Ana Aleman, Richard E. Champlin, David M. Gershenson, M. Donato, Robert C. Bast, Judith K. Wolf, Rima M. Saliba, Cindy Ippoliti, Thomas W. Burke, Ralph S. Freedman, J.T. Wharton, Charles F Levenback, Molly Brewer
Publikováno v:
Bone marrow transplantation. 33(12)
The purpose of this study was to identify characteristics significant to survival and progression-free survival in patients with advanced ovarian cancer receiving high-dose chemotherapy. In all, 96 patients received autologous stem cell transplantati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4883171d56a8a7a8e865ddd6ec7853e
https://pubmed.ncbi.nlm.nih.gov/15122311
https://pubmed.ncbi.nlm.nih.gov/15122311
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 12(6)
The objectives of this phase II protocol were: 1) to determine the clinical activity of thiotepa combined with cisplatin in suboptimally debulked advanced epithelial ovarian carcinoma as first-line chemotherapy, 2) to determine by surgery the respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fab4564b8d0760a297e9f5c045bfe75
https://pubmed.ncbi.nlm.nih.gov/12445247
https://pubmed.ncbi.nlm.nih.gov/12445247
Autor:
I. Papayannopoulos, Andrzej P. Kudelka, Stefano Stifani, Brett W. Anderson, B. Babcock, James L Murray, Agapito Castilleja, J.T. Wharton, C. G. Ioannides
Publikováno v:
Molecular immunology. 35(17)
In this study we investigated recognition by ovarian tumor associated lymphocyte (OVTAL), and breast tumor associated lymphocytes (BRTAL), of peptides corresponding to the sequence 125–135 of the Aminoenhancer of split (AES) protein. Three of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bb1de31638d10e872e3be35d77b67e4
https://pubmed.ncbi.nlm.nih.gov/10395201
https://pubmed.ncbi.nlm.nih.gov/10395201
Autor:
J.T. Wharton, C. G. Ioannides, George E. Peoples, Andrzej P. Kudelka, Brett W. Anderson, B Fisk
Publikováno v:
Annals of surgical oncology. 5(8)
Tumor-associated lymphocytes (TAL) isolated from ovarian cancer patients contain cytotoxic T lymphocytes (CTL) capable of recognizing specific HLA/peptide complexes on tumor cells leading to tumor cell lysis. Currently, HER2/neu, overexpressed in onl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::819a098a04585b3e80632f8a72d74663
https://pubmed.ncbi.nlm.nih.gov/9869522
https://pubmed.ncbi.nlm.nih.gov/9869522